“I think it’s really important that people keep signing up to these type of trials to push research forward.”
A study looking at biomarkers in people with kidney cancer
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This study is looking at chemicals and proteins called
Doctors know that people with kidney cancer have biomarkers in their blood and urine. They want to find out more about how these could be used to help diagnose and monitor kidney cancer treatment in the future.
The aim of this study is to find out more about biomarkers in people with kidney cancer to try and improve treatment in the future.
Who can enter
You may be able to enter this trial if you
- Have a type of kidney cancer called clear cell kidney cancer
- Have just been told you have kidney cancer or your kidney cancer has come back after surgery to remove your kidney
- Are at least 18 years old
You cannot enter this trial if you
- Have already had treatment for kidney cancer that reaches your whole body (
systemic treatment) except for immunotherapy, provera or bisphosphonates
- Are known to be HIV, hepatitis B or hepatitis C positive
- Have had any other cancer
- Have an
autoimmune diseasesuch as rheumatoid arthritis or lupus. Your doctor will discuss this with you
You have a blood and urine test on the day you agree to the study and then another one between 2 and 21 days later. This is the end of your participation in the study.
The study will not affect your treatment for kidney cancer.
Researchers plan to take your blood and urine samples on the days you are in clinic. If this is not possible you may have one extra hospital visit for the study.
As there are no treatments involved in this trial, the only side effect you may have is a small bruise when the blood sample is taken.
How to join a clinical trial
Professor Duncan Jodrell
Cambridge University Hospitals NHS Foundation Trust
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research (NIHR)
NIHR Cambridge Biomedical Research Centre